Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Short LLY ETF

8.57
0.0000
Volume:- -
Turnover:- -
Market Cap:1.54M
PE:- -
High:8.57
Open:8.57
Low:8.57
Close:8.57
52wk High:21.15
52wk Low:7.63
Shares:180.00K
Float Shares:180.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Eli Lilly and Company Just Beat Revenue By 11%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Aug 08

Mediar Therapeutics Signs Collaboration, Option Deal with Ono Pharma on Fibro-Inflammatory Disease Antibodies

Reuters
·
Aug 07

Eli Lilly : Truist Securities Raises Target Price to $1376 from $1370

THOMSON REUTERS
·
Aug 07

Morning BID Americas-Dealjà Vu

Reuters
·
Aug 07

Truist Adjusts Price Target on Eli Lilly & Co. to $1,376 From $1,370, Maintains Buy Rating

MT Newswires Live
·
Aug 07

8 ‘trendsetter’ stocks for world’s top mega-trends: Jon Erlichman

Bloomberg
·
Aug 07

Eli Lilly's Incretin Performance Supports Long-Term Growth, Truist Says

MT Newswires Live
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Eli Lilly Outperformance and Incretin Momentum Support Buy Rating with Unchanged $1,385 Price Target

TIPRANKS
·
Aug 06

Rumors Swirl That Eli Lilly (LLY) Will Split Its Stock After Blockbuster Earnings

TIPRANKS
·
Aug 06

Eli Lilly is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 06

Scotiabank Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 06

Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients

Dow Jones
·
Aug 06

Eli Lilly price target raised to $1,419 from $1,347 at Morgan Stanley

TIPRANKS
·
Aug 06

Wells Fargo Adjusts PT on Eli Lilly and Co. to $1,330 From $1,280, Maintains Overweight Rating

MT Newswires Live
·
Aug 06